United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Sells 60,802 Shares of CME Group Inc. (NASDAQ:CME)

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lessened its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 45.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,625 shares of the financial services provider’s stock after selling 60,802 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in CME Group were worth $15,295,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Power Corp of Canada bought a new position in CME Group in the 1st quarter valued at approximately $26,000. OFI Invest Asset Management acquired a new stake in shares of CME Group during the third quarter worth $25,000. MayTech Global Investments LLC acquired a new stake in shares of CME Group during the fourth quarter worth $25,000. Harbor Investment Advisory LLC increased its position in shares of CME Group by 966.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after buying an additional 145 shares during the period. Finally, Covestor Ltd increased its position in shares of CME Group by 65.7% during the first quarter. Covestor Ltd now owns 169 shares of the financial services provider’s stock worth $40,000 after buying an additional 67 shares during the period. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CME shares. Rosenblatt Securities reiterated a “sell” rating and set a $180.00 price objective on shares of CME Group in a research report on Thursday, January 4th. Barclays increased their price objective on shares of CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research report on Monday, April 8th. Morgan Stanley increased their price objective on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. The Goldman Sachs Group cut shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target for the company. in a report on Wednesday, January 3rd. Finally, Keefe, Bruyette & Woods restated a “market perform” rating and issued a $229.00 price target on shares of CME Group in a report on Wednesday, April 3rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $215.70.

Read Our Latest Stock Analysis on CME Group

CME Group Stock Performance

CME stock traded up $1.94 during mid-day trading on Wednesday, hitting $208.42. The company had a trading volume of 1,851,475 shares, compared to its average volume of 1,769,916. The firm has a market cap of $75.03 billion, a PE ratio of 23.45, a price-to-earnings-growth ratio of 5.86 and a beta of 0.49. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 12 month low of $175.73 and a 12 month high of $223.80. The stock’s fifty day moving average price is $214.09 and its two-hundred day moving average price is $211.65.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, topping the consensus estimate of $2.27 by $0.10. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The company’s revenue for the quarter was up 19.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.92 earnings per share. On average, analysts forecast that CME Group Inc. will post 9.56 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.21%. CME Group’s dividend payout ratio (DPR) is presently 51.86%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.